| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Unrealized loss on securities | - | 1 | 1 | - |
| Total other expense | -449 | -420 | -357 | -533 |
| Net (loss)/income | -638 | -3,152 | -1,165 | -5,735 |
| Earnings per share, basic | -0.02 | -0.11 | -0.04 | -0.21 |
| Earnings per share, diluted | -0.02 | -0.11 | -0.04 | -0.21 |
| Weighted average number of shares outstanding, basic | 27,889,000 | 27,664,000 | 27,578,000 | 27,371,000 |
| Weighted average number of shares outstanding, diluted | 27,889,000 | 27,664,000 | 27,578,000 | 27,371,000 |
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)